The independent source for health policy research, polling, and news.
521 - 540 of 919 Results
The cash represents an unprecedented opportunity to derail the opioid epidemic, but with countless groups advocating for their share of the pie, the impact could depend heavily on geography and politics.
Hospitals strike deals with financing companies, generating profits for lenders, and more debt for patients.
Low-income residents in states that haven’t expanded Medicaid are in a tough spot: They don’t qualify for the subsidies that people with slightly higher incomes get to buy marketplace plans because of a glitch in the federal health law. But a court decision last year makes it easier for them to make good-faith estimates of a pay increase, and there is no financial penalty if they don’t hit that figure.
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.
As the covid-19 pandemic raged, an independent nonprofit tied to the Centers for Disease Control and Prevention hired an army of seasoned professionals to fill the gaps in the country’s public health system. Now, the money has largely run out, and state and local health departments are again without their expertise.
Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.
South Dakotans voted to expand the state’s Medicaid program to cover thousands of additional low-income residents. But as other conservative states have shown, voter approval doesn’t always mean politicians and administrators will rush to implement the change.
Although control of Congress was still undecided Wednesday, Republicans seemed poised to take power in the House, while the fate of the Senate remained too close to call. Economic issues were at the top of voters’ minds, but abortion access also played a large role in their decisions.
Women who need abortion care come to Michigan from surrounding states that already have banned the procedure. A clinic in suburban Detroit allowed a reporter to interview patients, doctors, and nurses to understand what is at stake as voters decide whether to guarantee abortion access in the Michigan Constitution.
An Indiana man's family sued a state-owned nursing home for alleged mistreatment. A U.S. Supreme Court decision in the case could determine the right of many Americans to sue government agencies.
Centene, the largest Medicaid managed-care company in the U.S., has thrown more than $26.9 million at political campaigns across the country since 2015, especially focused on states where it is wooing Medicaid contracts and settling accusations that it overbilled taxpayers. Among its tactics: Centene is skirting contribution limits by giving to candidates through its many subsidiaries.
Federal officials have ordered the probe after reports that a woman whose water broke at 18 weeks could not get medical care recommended by her doctors to end the pregnancy because hospital officials were concerned about Missouri’s strict abortion law.
The 2018 farm bill that legalized hemp created a loophole for an unregulated copycat of marijuana. A form of delta-9 THC — the psychoactive substance in pot — doesn’t face the same laws and regulations as marijuana because it comes from hemp. The drug is poised to upend the cannabis industry.
Complaints about misleading health insurance marketing are soaring. State insurance commissioners are taking notice. They’ve created a shared internal database to monitor questionable business practices, and, in the future, they hope to provide a public-facing resource for consumers. In the meantime, consumers should shop wisely as open enrollment season begins.
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?
A medical billing specialist investigated her husband’s ER bill. Her sleuthing took over a year but knocked thousands of dollars off the hospital’s charges — and provides a playbook for other consumers.
Public transit is already insufficient in rural areas, leaving residents with few options as they travel greater distances to access health care. But older residents who depend on volunteer drivers to get them to appointments face another challenge: The number of those volunteers is declining.
As Michigan and several other states await voters’ verdicts on ballot measures about abortion, the providers, patients, and activists on both sides strategize their next steps.
With the midterm elections rapidly approaching, President Joe Biden has taken to the road to convince voters that he and congressional Democrats have delivered for them during two years in power. Among the health issues highlighted by the administration this week are pandemic preparedness and the availability of over-the-counter hearing aids. The president also promised to sign a bill codifying the abortion protections of Roe v. Wade if Democrats maintain control of the House and Senate — even though it’s a long shot that there will be enough votes for that. Sarah Karlin-Smith of the Pink Sheet, Sandhya Raman of CQ Roll Call, and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Veterans Affairs’ electronic health records aren’t friendly to blind- and low-vision users, whether they’re patients or employees. It’s a microcosm of America’s health care system.
© 2026 KFF